Myelodysplastic syndromes (preleukemia)

Semin Hematol. 1986 Oct;23(4):284-99.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Blood Transfusion
  • Bone Marrow Transplantation
  • Calcitriol / therapeutic use
  • Cell Differentiation / drug effects
  • Chromosome Aberrations
  • Combined Modality Therapy
  • Humans
  • Leukemia, Myeloid, Acute / etiology
  • Mutagens / adverse effects
  • Myelodysplastic Syndromes / chemically induced
  • Myelodysplastic Syndromes / genetics
  • Myelodysplastic Syndromes / pathology*
  • Myelodysplastic Syndromes / therapy
  • Neoplasms, Radiation-Induced / etiology
  • Neoplastic Stem Cells / pathology
  • Preleukemia / chemically induced
  • Preleukemia / genetics
  • Preleukemia / pathology*
  • Preleukemia / therapy
  • Prognosis
  • Risk

Substances

  • Mutagens
  • Calcitriol